 |
humanized IgG1 monoclonal antibody targeting KIR3DL2 |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-14 00:00:00 |
| Sponsor | Innate Pharma;117 Avenue de Luminy, BP 30191;Marseille |
Related Access Program